Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosimetry and Clinical Application of 68Ga-dPNE in Malignant Tumors
NCT06995976Phase 1Completed
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-dPNE in cancer (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Standardized Uptake Value of tumors at 3 months. Started Mar 2025; status: completed.
02
Drugs
68Ga-dPNE
03
Conditions
cancer
Beyond the preview
Go deeper on NCT06995976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995976.